Company news
Medical Marijuana, Inc. (OTC:MJNA) news
Medical Marijuana, Inc. news releases on 6ix. Latest, Sep 4, 2020: Medical Marijuana, Inc. Announces Production and Warehouse Facility Expansion; Adds…
Press releases — page 3
Medical Marijuana, Inc. Announces Production and Warehouse Facility Expansion; Adds State-of-the-Art Manufacturing Capability and Hemp License
September 4, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Begins Recruiting CBD Users for ValidCare Virtual Study™
September 2, 2020
Medical Marijuana, Inc. Announces Key Executive Team Hire and Promotions
September 1, 2020
Medical Marijuana, Inc. Announces Sales Operations Milestone; Sells More Than 1.6 Billion Milligrams of CBD
August 27, 2020
Medical Marijuana, Inc. Reports 2020 Second Quarter Financial and Operational Results; Reports Net Income of $9.7 Million
August 25, 2020
Medical Marijuana, Inc. CEO Featured in Reuters Highlighting Recent M&A Shifts in the Cannabis Industry
August 18, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 2020 as Best Month in Company History for Japanese Division
August 13, 2020
Medical Marijuana, Inc. Subsidiary Kannaway Sports Team Welcomes Former NHL and Network Marketing Veteran Mike Hartman
August 11, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Supports European Industrial Hemp Association in Opinion Letter on Legal Status of CBD and Hemp
August 4, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Distinguished Sales and Marketing Expert Carolyn Dielmann Connolly as Brand Ambassador
July 30, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Unveils World’s First COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization
July 21, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in 12 Key European Territories
July 9, 2020
HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches CBD Topical and Beauty Products at Gelson’s Market
July 7, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History
July 6, 2020
Medical Marijuana, Inc. Reports 2020 First Quarter Financial and Operational Results
July 1, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance
June 30, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico
June 23, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Appoints Vince DiMella as U.S. Director of Sales and Marketing
June 16, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference
June 11, 2020
Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors
June 4, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech
May 28, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes NBA Veteran Earl Monroe
May 26, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company
May 22, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker
May 21, 2020
Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®
May 19, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program
May 11, 2020
Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer
May 7, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules
May 5, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Largest Digital Event in Company History
April 30, 2020
Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA
April 29, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International
April 22, 2020
Blake Schroeder, CEO of Medical Marijuana, Inc. Subsidiary Kannaway®, Honored as Top CEO of the Year by the International Association of Top Professionals
April 16, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President
April 14, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™
April 9, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine
April 8, 2020
Medical Marijuana, Inc. CEO Featured in U.S. News and World Report Providing Insight on Penny Stocks
April 2, 2020
HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors
March 31, 2020
Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry
March 26, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
March 24, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders
March 19, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Becomes First Company to Legally Import CBD Products Into Russia
March 17, 2020
Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection
March 12, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp + Calm CBD Oral Applicator in Europe
March 10, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)
March 5, 2020
HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical
February 27, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston
February 25, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent
February 20, 2020
Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor
February 18, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University
February 13, 2020
Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise
February 11, 2020